MedPath
HSA Approval

VALGAN 450 VALGANCICLOVIR FILM-COATED TABLET 450 MG

SIN15779P

VALGAN 450 VALGANCICLOVIR FILM-COATED TABLET 450 MG

VALGAN 450 VALGANCICLOVIR FILM-COATED TABLET 450 MG

August 14, 2019

MEDICELL PHARMACEUTICAL (S) PTE. LTD.

MEDICELL PHARMACEUTICAL (S) PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantMEDICELL PHARMACEUTICAL (S) PTE. LTD.
Licence HolderMEDICELL PHARMACEUTICAL (S) PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

J05AB14

valganciclovir

Manufacturer Information

MEDICELL PHARMACEUTICAL (S) PTE. LTD.

Hetero Labs Limited

Active Ingredients

Valganciclovir Hydrochloride 496.3 mg equivalent to Valganciclovir

450 MG

Valganciclovir

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

VALGAN 450 VALGANCICLOVIR FILM-COATED TABLET 450 MG - HSA Approval | MedPath